HIV-1 Genotyping, DNA Sequencing : 34949

HIV1G or 34949

Human Immunodeficiency Virus 1, Genotyping; HIV Genotype

Lavender (EDTA).

Separate plasma from cells within 24 hours. Transfer 2 mL plasma to a standard transport tube. (Min: 0.6 mL)
 

Frozen.

After separation from Cells: Ambient: 24; Refrigerated: 6 days; Frozen: 42 days
Note: Plasma must be removed from cells within 24 hours of collection.

Heparinized specimens. Frozen whole blood. Serum.

Sunday - Saturday

4-9 days (From receipt at performing laboratory)

An infection is often composed of a variety of strains of the virus. The test may identify only the predominant type of virus thus leaving the minority viruses to thrive once the predominant type is treated. Lack of resistance may not confer susceptibilities.

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

By report.

This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test identifies drug resistance-associated mutations in the HIV-1 protease and reverse transcriptase genes. It can be used to predict antiretroviral drug resistance before initiation of therapy and in patients experiencing virologic failure while on therapy.